Abstract
ALX40-4C is an antiretrovirus agent that has been found to have some inhibitory properties against human immunodeficiency virus (HIV) replication in vitro. The compound was designed as a competitor of the HIV Tat protein for TAR binding. In addition to its anti-HIV properties, it has demonstrated the ability to inhibit in vitro replication of herpes simplex virus types 1 and 2 as well as human cytomegalovirus. Subsequently, in vivo pharmacokinetic evaluation of ALX40-4C necessitated the establishment of a detection system for the measurement of ALX40-4C in subject serum. For this purpose, an indirect-competition enzyme-linked immunosorbent assay with generated rabbit anti-ALX40-4C antiserum was developed. The original assay took 12 h to complete and required many manipulations. Herein, we describe alterations to the system that resulted in the overall reduction in assay time and manipulation. We demonstrate that our alterations do not affect the specificity or sensitivity of the assay compared to that of the original system. ALX40-4C levels in spiked serum samples as well as drug levels from patient samples were used to validate the assay.
Full Text
The Full Text of this article is available as a PDF (178.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol. 1980 Feb;39(2):426–434. [PMC free article] [PubMed] [Google Scholar]
- Cantarero L. A., Butler J. E., Osborne J. W. The adsorptive characteristics of proteins for polystyrene and their significance in solid-phase imunoassays. Anal Biochem. 1980 Jul 1;105(2):375–382. doi: 10.1016/0003-2697(80)90473-x. [DOI] [PubMed] [Google Scholar]
- Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
- Guesdon J. L., Ternynck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem. 1979 Aug;27(8):1131–1139. doi: 10.1177/27.8.90074. [DOI] [PubMed] [Google Scholar]
- Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
- Kemeny D. M. Titration of antibodies. J Immunol Methods. 1992 Jun 24;150(1-2):57–76. doi: 10.1016/0022-1759(92)90065-2. [DOI] [PubMed] [Google Scholar]
- Klinman N. R., Press J. L. The B cell specificity repertoire: its relationship to definable subpopulations. Transplant Rev. 1975;24:41–83. doi: 10.1111/j.1600-065x.1975.tb00165.x. [DOI] [PubMed] [Google Scholar]
- O'Brien W. A., Sumner-Smith M., Mao S. H., Sadeghi S., Zhao J. Q., Chen I. S. Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions. J Virol. 1996 May;70(5):2825–2831. doi: 10.1128/jvi.70.5.2825-2831.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Porstmann T., Kiessig S. T. Enzyme immunoassay techniques. An overview. J Immunol Methods. 1992 Jun 24;150(1-2):5–21. doi: 10.1016/0022-1759(92)90061-w. [DOI] [PubMed] [Google Scholar]
- Sumner-Smith M., Zheng Y., Zhang Y. P., Twist E. M., Climie S. C. Antiherpetic activities of N-alpha-acetyl-nona-D-arginine amide acetate. Drugs Exp Clin Res. 1995;21(1):1–6. [PubMed] [Google Scholar]
- Voller A., Bidwell D., Huldt G., Engvall E. A microplate method of enzyme-linked immunosorbent assay and its application to malaria. Bull World Health Organ. 1974;51(2):209–211. [PMC free article] [PubMed] [Google Scholar]
- Wilchek M., Bayer E. A. Introduction to avidin-biotin technology. Methods Enzymol. 1990;184:5–13. doi: 10.1016/0076-6879(90)84256-g. [DOI] [PubMed] [Google Scholar]